Januarie / January 2026 The Monthly Magazine of the SOUTH AFRICAN VETERINARY ASSOCIATION Die Maandblad van die SUID-AFRIKAANSE VETERINÊRE VERENIGING Neurological and Musculoskeletal disorders of backyard poultry CPD THEME Avian nuus•news Access to CPD Articles: https://www.sava.co.za/vetnews-2026/ VET
Dagboek • Diary June 2026 September 2026 13th Int Crustacean Society Mid-Year Meeting 01-04 June Venue: STIAS – Stellenbosch Info: https://tcs2026.com/ NVCG Bush Break 06-07 June Venue: Skukuza, Kruger National Park Info: Vetlink: https://vetlink.co.za/nvcg-bush-break-2026/ RuVASA Congress 2026 08 - 10 June Venue: Champagne Sports Resort, Drakensberg, KZN Info: https://vetlink.co.za/ruvasa-congress-2026/ Virology Africa Congress 15 - 18 September Venue: Skukuza, Kruger National Park Info: Vetlink: https://virologyafrica2026.co.za/ NVCG: The Vet Masterclass: Medicine & Dermatology 19 - 20 September Venue:Johannesburg, Midrand Premier Hotel 21 - 22 September Venue: Cape Town Chrystal Towers, Century City Vetlink: https://vetlink.co.za/nvcg-roadshow-dermmed/ or +27 12 346 1590 SAAVT Biennial Congress 30 September - 01 October Venue: Krystal Beach Hotel – Gordon’s Bay Info: conference@savetcon.co.za 13th Biennial SAVA & Para-Veterinary Congress Postponed until early 2027 Venue: to be confirmed (Gauteng) Info: corne@savetcon.co.za Watch this space for more information. Ongoing / Online 2026 February 2026 March 2026 May 2026 SAVETCON: Webinars Info: Corné Engelbrecht, SAVETCON, 071 587 2950, corne@savetcon.co.za / https://app.livestorm.co/svtsos SAVA Johannesburg Branch CPD Events Monthly - please visit the website for more info. Venue: Johannesburg Country Club Info: Vetlink - https://savaevents.co.za/ SAEVA Congress 2026 19 - 22 February Venue: Champagne Sports Resort, Drakensberg, KwaZulu Natal Info: https://vetlink.co.za/saeva-congress-2026/ Wildlife Group of the SAVA Congress 2026 12 - 14 March Venue: 26° South Hotel , Muldersdrift, Gauteng Info: https://vetlink.co.za/wildlife-group-2026/ NVCG: The Veterinary Masterclass: Neurology 17 - 18 March Venue: Cape Town Chrystal Towers, Century City 19 - 20 March Venue: Johannesburg, Midrand Premier Hotel Vetlink: https://vetlink.co.za/nvcg-roadshow-march/ or +27 12 346 1590 UP: Beyond Basics: Mastering the Cardio-respiratory Patient: A Structured Clinical Approach 11 - 12 May Venue: Premier Hotel, Midrand, Gauteng Info: https://vetlink.co.za/beyond-basics/
Vetnuus | January 2026 1 Contents I Inhoud President: Dr Ziyanda Qwalela president@sava.co.za Interim General Manager: Ms Sonja Ludik sonja@sava.co.za/ +27 (0)12 346 1150 Editor VetNews: Ms Andriette van der Merwe vetnews@sava.co.za Accounts / Bookkeeping: Ms Shaye Hughes accounts@sava.co.za/+27 (0)12 346 1150 Reception: Ms Hanlie Swart reception@sava.co.za/ +27 (0)12 346 1150 Marketing & Communications: Ms Sonja van Rooyen marketing@sava.co.za/ +27 (0)12 346 1150 Membership Enquiries: Ms Debbie Breeze debbie@sava.co.za/ +27 (0)12 346 1150 Vaccination Booklets: Ms Debbie Breeze debbie@sava.co.za/ +27 (0)12 346 1150 South African Veterinary Foundation: Ms Debbie Breeze savf@sava.co.za/ +27 (0)12 346 1150 Community Veterinary Clinics: Ms Claudia Cloete manager@savacvc.co.za/ +27 (0)63 110 7559 SAVETCON: Ms Corné Engelbrecht corne@savetcon.co.za/ +27 (0)71 587 2950 VetNuus is die amptelike publikasie van die Suid Afrikaanse Veterinêre Vereeniging (SAVV). Alle regte word voorbehou. Geen deel van hierdie publikasie mag aangehaal, gedupliseer, versprei of aan die publiek beskikbaar gestel word in enige vorm sonder die uitdruklike skriftelike toestemming van die SAVV nie.Hierdie publikasie is uitsluitelik bedoel vir veearts en veearts verwante professionele persone soos deur die Suid Afriaanse Veterinêre Raad erken word. Wyl alles moontlik gedoen word om om die akkuraatheid van die inhoud te verseker, aanvaar nie die redaksie, SAVV of enige van die personeel, lede, werknemers of agente enige regsaanspreeklikheid vir enige verlies, skade of bevooroordeeldheid, hetsy direk of indirek, wat mag spruit uit enige stelling, feit, opinie, advertensie of aanbeveling hierin gepubliseer. Enige advertensie of verwysing na n spesifieke produk is toevallig en word nie noodwending onderskryf of aanbeveel deur die SAVV nie. VetNews is the official publication of the South African Veterinary Association (SAVA). All rights are reserved. No part of this publication may be quoted, reproduced, distributed, or made publicly available in any form or by any means without the prior express written consent of SAVA. This publication is intended solely for veterinarians and paraveterinary professionals as recognised by the South African Veterinary Council. While every effort is made to ensure the accuracy of the content, neither the editorial board, SAVA, nor any of its office bearers, members, employees, or agents shall be held liable for any loss, damage, or prejudice, whether direct or consequential, arising from any statement, fact, opinion, advertisement, or recommendation published herein. The inclusion of advertising or reference to specific products or services does not imply endorsement by SAVA. STREET ADDRESS 47 Gemsbok Ave, Monument Park, Pretoria, 0181, South Africa POSTAL ADDRESS P O Box 25033, Monument Park Pretoria, 0105, South Africa TELEPHONE +27 (0)12 346-1150 FAX General: +27 (0) 86 683 1839 Accounts: +27 (0) 86 509 2015 WEB www.sava.co.za CHANGE OF ADDRESS Please notify the SAVA by email: debbie@sava.co.za or letter: SAVA, P O Box 25033, Monument Park, Pretoria, 0105, South Africa CLASSIFIED ADVERTISEMENTS (Text to a maximum of 80 words) Sonja van Rooyen assistant@sava.co.za +27 (0)12 346 1150 DISPLAY ADVERTISEMENTS Sonja van Rooyen assistant@sava.co.za +27 (0)12 346 1150 DESIGN AND LAYOUT Sonja van Rooyen PRINTED BY Business Print: +27 (0)12 843 7638 VET Diary / Dagboek II Dagboek • Diary Regulars / Gereeld 2 From the President 4 Editor’s notes / Redakteurs notas Articles / Artikels 6 A raw deal: the intersection of the immunocompromised cat, influenza, and a lapse of infection prevention and control measures 9 Unprecedented high level of highly pathogenic avian influenza in wild birds in Europe during the 2025 autumn migration 12 Viral Diseases of Pet Birds 18 Novel Combination Products for the Prevention and Treatment of Parasitic Fly Infested Wound Sites in Zoo Animals 28 The Blood Transfusion Association / Vereniging 30 CVC News 34 SAVA News 38 SAVA Benefits 40 In Memoriam Vet's Health / Gesondheid 42 Life Coaching Technical / Tegnies 44 Dental Column Marketplace / Markplein 46 Marketplace Jobs / Poste 47 Jobs / Poste 48 Classifieds / Snuffeladvertensies 6 18 Click on the image to access Vetnews CPD articles « nuus•news 37
Vetnews | Januarie 2026 2 « BACK TO CONTENTS As we begin 2026, this January edition of Vetnews is published against the backdrop of one of the most complex and consequential periods the veterinary profession in South Africa has faced in recent decades. Foot-andMouth Disease (FMD) continues to test not only our animal health systems, but also our collective ability to coordinate effectively across national, provincial, and local levels. The National Veterinary Services and the Ministerial Task Team are considering a comprehensive framework for responding to the current FMD epidemic—signalling an important shift toward a risk-based and progressive control pathway. It is our prayer that the strategy aimed at containing the disease is underpinned by strengthened surveillance, a robust animal identification system, zoning, effective movement control, collaboration with law-enforcement structures, and targeted vaccination measures designed to reduce widespread infection and progressively restore South Africa’s pre 2019 FMD disease status. FMD affects a broad spectrum of stakeholders—from communal farmers and commercial producers to feedlots, auctioneers, transporters, and the wildlife sector. Sustainable disease control will only be achieved where measures are proportionate, context-sensitive, and cognisant of the real economic and livelihood pressures faced at ground level by small commercial producers and the emerging sector. Compliance is strongest where systems are trusted, consistently enforced and visibly fair. As veterinarians, we sit at the critical intersection of policy and practice. Across all sectors, we bring the expertise, local insight, and trusted relationships needed to make disease control work in real-world conditions. The FMD epizootic has also reinforced the importance of strong local action supported by national coordination, as well as the necessity of the profession’s collective commitment to evidence-based decisions, ethical leadership, and shared accountability. Veterinary structures remain vital in aligning national priorities with the realities faced by practitioners on the ground, and I trust that our members will rise to the occasion. During December, there was a SAVA Board meeting, which, amongst others, considered key issues affecting the sustainability, governance, and future direction of the Association and the profession. It was a vibrant and constructive meeting, bringing together incoming and outgoing Board members and generating thoughtful discussion and fresh perspectives. The Board reviewed the Association’s financial position and reaffirmed the need for continued careful financial management to strengthen long-term sustainability and ensure ongoing support to members. As communicated previously, the Association has significantly reduced its overheads and, while challenges remain, meaningful progress is being made towards achieving the required financial stability. Organisational and affiliate relationships were also discussed. A key focus for the first quarter of the year will be the finalisation of memoranda of understanding and other governance arrangements, alongside strengthened accountability mechanisms and improved communication with groups and branches. In response to growing concerns around changes in veterinary practice, including professional independence and corporate ownership, the SAVA Board agreed to engage members further on this matter through polls, surveys, and structured discussions, including a dedicated session at the next SAVA congress. On animal welfare matters, the Board considered the results of the member poll on the transport of live animals for slaughter and agreed on a balanced organisational position. This approach supports a progressive move towards ending the practice, while recognising animal welfare concerns alongside the current regulatory framework of the country, as well as the practical and economic realities faced by veterinarians and producers. SAVA will also explore the development of practical welfare guidelines to support veterinarians working in this area. Congress planning was reviewed, with a focus on ensuring future events remain relevant, accessible, and financially sustainable. While preliminary logistics are still being finalised by the Congress Planning Committee, it has been confirmed that the next SAVA Congress will be held in 2027. The Board also acknowledged the importance of member well-being and agreed to strengthen its focus on mental health and professional support initiatives. Overall, the Board acknowledged the concerns expressed by groups and branches through various engagements and reaffirmed its commitment to transparent governance, responsible financial stewardship, and ongoing engagement with members, recognising that a strong and stable association is essential in navigating current and future challenges. In closing, I would like to mention that it has come to light that some members were under the impression that Vetlink would no longer be providing services and was closing. We have since engaged directly with Vetlink, who have unequivocally confirmed that this is not the case and that they remain fully operational. We wish to clarify this to members and sincerely apologise to Vetlink for any inconvenience this may have caused. As we step into this new year, may it be one marked by renewed purpose, strengthened partnerships, and confidence in our collective ability to meet the challenges before us. The road to controlling FMD will demand resilience, discipline, and cooperation—but it also offers an opportunity to reaffirm who we are as a profession: principled, service-driven, and united in our commitment to animal health, public trust, and national well-being. With clarity of vision and shared resolve, 2026 can be a year of progress, restoration, and renewed hope. v Groetnis! Ziyanda From the President Dear members, A Brand-New Start
Vetnuus | January 2026 3 To find out more: You are looking for a be琀琀er way to exit from or sell your practice. You want to become a shareholder. www.companion.partners WhatsApp View Video Download Value Proposition co.mpanion is not a corporate body, it is a professional owned and led veterinary model that is right for you if: Building be琀 琀er practice together. co.llaborative model that gives you the ownership, support and autonomy Image: Dr Werner Odendaal, Shareholder & Team Member, To find out more: You are looking for a be琀琀er way to exit from or sell your practice. You want to become a shareholder. www.companion.partners WhatsApp View Video Download Value Proposition co.mpanion is not a corporate body, it is a professional owned and led veterinary model that is right for you if: Building be琀 琀er practice together. co.llaborative model that gives you the ownership, support and autonomy Image: Sr Nicole琀琀e Fouché, Shareholder & Team Member,
Vetnews | Januarie 2026 4 « BACK TO CONTENTS Dear members I am sure that everybody has something to appreciate in 2025, even if it is the rain, or lack thereof, a flower or something done for you, an unexpected parking space, or an unexpected gift. I definitely take a lot of appreciation into 2026. It is not the big things, although significant things can change your life, and there is a lot of appreciation when it happens. We had the privilege of spending this Christmas with Paul’s 95-year-old mother. She undertook the journey from Pretoria to Hoedspruit with one of the daughters, spent about 10 days with us, and returned to the Care facility with one of the other daughters. It was a flurry of excitement and activities as we celebrated the days before, Christmas itself, and the days after. Cooking and chatting, catching up and planning, it buzzed. And yet she kept a cool head, quietly absorbing all the sometimes chaotic activities. When asked why she was so quiet, she merely replied that she was collecting memories for when it is quiet around her again. She climbed up the open safari vehicle, quietly pointing to animals she saw and was never a burden to anyone. As life goes, one has to appreciate one’s elders. You have to appreciate your peers, and you have to appreciate your children. I have many friends who suffered immense losses in 2025. It is never easy to see appreciation and gratefulness in difficult times. In 2026, I wish that everybody could find something to be appreciative of every single day. A Newyears resolution could be to start a journal and jot down your blessings every day. In 365 days, you will have collected 365 blessings, things to be appreciative of. In this month’s edition, we look at some birdy things. With the FMD and rabies rife, we forget about bird flu and the like. We look at the transmission of highly pathogenic avian influenza to a cat, some statistics out of Europe of the autumn 2025 wild bird migration, and also a bit about Viral diseases in Pet Birds as a bit of a refresher for members who do not see birds that often (my former Employer still calls all birds chickens, and I nearly did it here), then some novel combination products to combat infected wound sited in zoo animals. There is also an updated compound diary listing of all known events in 2026, for your planning. My wish for 2026 for you is good health, uplifted spirits, camaraderie, and more moments of appreciation than you can handle. See you all in February with the theme of Ruminants – large and small. Andriette v From the Editor Appreciation in the Oxford Languages (good old Google) returns a couple of meanings; The recognition and enjoyment of the good qualities of someone or something, o Gratitude o A written assessment of an artist or piece of work, typically a favourable one. A full understanding of a situation An increase in monetary value. Editor’s notes / Redakteurs notas
Vetnuus | January 2026 5 We offer a wide range of veterinary supplies to meet your practice’s or business’s needs. Access high-quality, affordable equipment, medicine and products. TRUSTED VETERINARY SUPPLIES & PRODUCTS AVAILABLE: See it, love it, own it! Virtual Window Shopping! Step into our digital storefront and indulge in www.transpharm.co.za We Service All: • Veterinarians • Pet Shops • Breeders/Farmers • Grooming Parlours Vets WE TAKE CARE OF YOUR ANIMALS HEALTH CLICK TO VIEW OUR RANGE BEDS & BEDDING PET FOOD & TREATS ACCESSORIES HYGIENE & GROOMING HEALTH & WELLNESS REGISTERED VET
Vetnews | Januarie 2026 6 « BACK TO CONTENTS A raw deal: the intersection of the immunocompromised cat, influenza, and a lapse of infection prevention and control measures Kelli J. Maddock1 https://doi.org/10.1128/ asmcr.00134-25. ABSTRACT The case report by Chen et al. (ASM Case Rep 1:e00134-25, 2025, https:// doi.org/10.1128/asmcr.00134-25) importantly describes nosocomial transmission of s in an immunocompromised resident clinic cat. This case highlights several significant public health threats, starting with HPAI spillover from birds to cats, foxes, and cattle; probable HPAI infection due to contaminated commercially prepared raw pet foods; nosocomial infection of an immunocompromised animal; and lapses in infection prevention and control (IPC) measures. This case underscores the need for formal IPC guidelines or a risk assessment-based protocol for resident clinic or personal pets in veterinary settings. As the availability of and interest in using commercial raw pet foods increase, there is a need for education surrounding infectious disease risk, safe handling, and handwashing procedures for use of these products, as well as the potential risk for faecal shedding of important enteric pathogens. Further emphasising the importance of IPC, nosocomial outbreaks caused by Salmonella and antimicrobial-resistant bacteria have been identified in large animal and companion animal practices, with a recent case describing probable zoonotic and nosocomial spread of carbapenem-resistant organisms. To mitigate these risks, veterinary practices (clinics or hospitals) require resources and education for IPC to minimise and investigate nosocomial transmission of infectious diseases. Finally, the availability of highquality point-of-care test options for veterinary infectious diseases would support human, animal, and population health by providing rapid and actionable results for disease response. The case report by Chen et al. (1) describes a nosocomial infection of highly pathogenic avian influenza (HPAI) H5N1 in an immunocompromised domestic cat. The cat was a resident of the clinic and had contact with clinic spaces and personnel who had previous contact with another cat experiencing respiratory illness after consumption of recalled (2), potentially HPAI-contaminated raw cat food. This case represents an interesting intersection of an immunocompromised resident of a veterinary clinic and several public health phenomena of our time, namely, the spillover of HPAI from birds to cats, foxes, and cattle; the raw pet food diet trend; and an increasing need for infection prevention and control (IPC) measures in veterinary practices (clinics or hospitals). Beyond these factors, human, animal, and population health, and potentially antimicrobial stewardship, could be supported by increased availability of high-quality infectious disease point-of-care testing (POCT) in veterinary practices. It is not uncommon for veterinary practices to adopt resident clinic pets with difficult-to-manage conditions that may be too challenging or expensive for the average pet owner to navigate. While surrounding these animals with veterinary professionals and providing care is altruistic, paradoxically, they are also residing in an environment where they may be at a high risk of contracting a debilitating or lethal illness from other patients. While no formal IPC guidance or policy currently exists for personal or clinic-residing pets, there is a significant biosecurity risk and the potential for infectious disease spread for these animals, particularly if they are also immunocompromised. In 2019, the American Society for Microbiology drafted formal guidance for service animals in teaching laboratory settings (3), with emphasis placed on protecting both the animal and people in the space from physical harm (trips and uncontrolled animals), biohazards, and biosecurity risks. Veterinary practices should evaluate potential risks to these resident clinic pets and whether procedural control or physical segregation from common areas that may be contaminated by other patients is sufficient to protect these vulnerable animals. In recent years, a trend toward providing raw pet food for perceived nutrition benefits (4–6) has become a more mainstream dietary option for pets, with multiple commercial vendors offering raw products marketed to pet owners. Despite numerous infectious disease events (7) and decades of evidence to the contrary (8), raw milk is also experiencing a new era of public perception as a nutritious, safe, and natural alternative to pasteurised dairy products for people and pets alike. Commercial raw pet foods have also been the subject of product recalls (2, 9, 10) due to potential HPAI contamination, and both raw pet foods and raw milk have been linked to HPAI infection in companion animals, including the probable source of HPAI in this case (1). While the risk of cat-to-human transmission of HPAI is currently low, raw diets introduce additional risks to pets and their owners. These products are often contaminated with ever-present gastrointestinal nemesis, Salmonella, Listeria monocytogenes, Campylobacter, and diarrheagenic Escherichia coli (4, 5, 11–13), with a recent outbreak involving raw pet food and a multidrug-resistant strain of Salmonella I 4, [5], 12:i:- (14). Pet owners may not realise that these raw commercial products require strict handling, just like human-grade meat products that are typically cooked. They also may be unaware of the risks associated with these raw products. Beyond product handling risk, there is an increased risk of faecal Salmonella shedding from pets who have consumed contaminated products (15, 16), increasing the risk of illness for pet owners or environmental contamination.
Vetnuus | January 2026 7 Leading Article Veterinary professionals, retailers, and commercial raw pet food companies share the responsibility to communicate these potential risks and provide safe handling resources to pet owners.Historically, data regarding hospital-acquired infections (HAIs) and IPC have been limited for veterinary medicine (17). Interactions with veterinary patients may seem less clinical than interactions with human patients, and hand hygiene, personal protective equipment use, and equipment or environmental decontamination may not be prioritised in some clinical settings until there is an adverse event requiring it to be. While documentation of HAI is scarce for most pathogens, the primary suspects in human HAIs are also of concern for veterinary settings (17). Salmonella outbreaks (17– 19) are well documented in large animal hospitals, and outbreaks caused by carbapenemase-producing organisms (CPOs) in companion animal practices were recently described in the United States (20–23). While it is possible that these CPO outbreaks are new phenomena, it is also possible that detection and reporting of these strains have been delayed or limited due to a lack of veterinary laboratory resources, knowledge, or procedures for public health reporting of these isolates from animals (24). Concerningly, a recent study (20) epidemiologically linked three human cases of infection with a CPO to a veterinary hospital where pets residing in these three separate households had received care, further highlighting the zoonotic and nosocomial risk of these outbreaks. Beyond risk to patients and their families, HAIs are expensive for veterinary practices and their patients, with cost estimates ranging from $25,000 for mitigation of a CPO outbreak (21) to $4.12 million in lost revenue and mitigation expenses (19) for a multidrug-resistant Salmonella outbreak. Importantly, lapses of IPC measures were identified in each Salmonella and CPO outbreak report. Finally, veterinary medicine would benefit from the availability of high-quality, rapid, infectious disease POCT (25), such as PCR panels for common viral, bacterial, and parasitic causes of illness like those employed in human medical settings. Rapid respiratory POCT could help rule in or out influenza and common viral or bacterial causes of respiratory illness, supporting rapid treatment and response to infectious disease. In the case of the initially presenting feline, a rapid influenza result may have prompted decontamination procedures and IPC measures, protecting animal population health. Again, while the risk of cat-to-human transmission of HPAI currently remains low, rapid detection of critical emerging infectious diseases from humans or animals is important in the post-pandemic watchful waiting period. Beyond infectious disease detection and transmission, rapid POCT could also enhance antimicrobial stewardship by supporting veterinarians in conversations with pet owners where antimicrobial treatments are requested by an owner for what is often a viral infection. Particularly in a time of wavering trust in public health (26), it is important for veterinarians and other health professionals to continue the low-cost preventative strategy of sharing the science and educating animal owners and the general public regarding the risks of raw diets for pets. Owners must be aware of the potential risks of using raw products for themselves and their animals, and veterinarians must feel empowered to discuss these risks as well as the need for strict handling and handwashing measures undertaken by the owners. Veterinary practices must have resources and support for IPC measures, including training for appropriate hand hygiene and personal protective equipment use, decontamination practices, and outbreak investigations. In the absence of formal IPC guidance or policies, veterinary practices should conduct risk assessments for personal and resident clinic pets. Resources should be allocated for the development of high-quality POCT to ensure the timely detection of infectious disease agents. Together, these measures will support IPC and safeguard human and animal health. REFERENCES 1. Chen C, Naru A, Mareddy VR, Lanka S, Olmstead C, RevindranStam V, Sherman M, Yee H, Loose N, Delaney MA, Vieson MD, Fang Y. 2025. Highly pathogenic avian influenza A H5N1 virus infection in an immunocompromised domestic cat. ASM Case Rep 1:e00134-25. https:// doi.org/10.1128/asmcr.00134-25 2. Food and Drug Administration. 2025. Savage pet recalls savage cat food chicken – large and small boxes because of possible bird flu health risk. Available from: https://www.fda. gov/safety/recalls-market-withdrawals-safety-alerts/savage- pet-recalls-savage-cat-food-chicken-large-and-small-boxes- because-possible-bird-flu-health 3. American Society for Microbiology. 2019. American society for microbiology. guidelines for biosafety in teaching laboratories. Available from:https://asm.org/guideline/asm-guidelines-forbiosafety-in-teachin g-laborator 4. Freeman LM, Chandler ML, Hamper BA, Weeth LP. 2013. Current knowledge about the risks and benefits of raw meat-based diets for dogs and cats. J Am Vet Med Assoc 243:1549–1558. https://doi.org/10.2460/javma.243.11.1549 5. Dhakal J, Cancio LPM, Deliephan A, Chaves BD, Tubene S. 2024. Salmonella presence and risk mitigation in pet foods: a growing challenge with implications for human health. Compr Rev Food Sci Food Saf 23:e70060. https://doi.org/10.1111/15414337.70060 6. Morgan G, Williams N, Schmidt V, Cookson D, Symington C, Pinchbeck G. 2022. A dog’s dinner: factors affecting food choice and feeding practices for UK dog owners feeding raw meatbased or conventional cooked diets. Prev Vet Med 208:105741. https://doi.org/10.1016/j.prevetmed.20 22.105741 >>>8
Vetnews | Januarie 2026 8 « BACK TO CONTENTS 7. Sebastianski M, Bridger NA, Featherstone RM, Robinson JL. 2022. Disease outbreaks linked to pasteurized and unpasteurized dairy products in Canada and the United States: a systematic review. Can J Public Health 113:569–578. https:// doi.org/10.17269/s41997-022-00614-y 8. US Food and Drug Administration. 2024. Raw milk misconceptions and the danger of raw milk consumption. Available from: https://www.fda.go v/food/buy-store-servesafe-food/raw-milk-misconceptions-and-danger-raw-milkconsumption 9. US Food and Drug Administration. 2025. FDA notifies pet owners that tests show H5N1 contamination in certain lots of RAWR raw cat food chicken eats. Available from: https://www. fda.gov/animal-veterinary/cvm-updates/fda-notifies-pet- owners-tests-show-h5n1-contamination-cer tain-lots-rawr- raw-cat-food-chicken-eats 10. US Food and Drug Administration. 2025. Voluntary recall of wild coast raw boneless free range chicken formula raw pet food because of possible bird flu health risk. Available from: https://www.fda.gov/safety/r ecalls-market-withdrawalssafety-alerts/voluntary-recall-wild-coast-rawboneless-freerange-chicken-formula-raw-pet-food-because-possible 11. Nemser SM, Doran T, Grabenstein M, McConnell T, McGrath T, Pamboukian R, Smith AC, Achen M, Danzeisen G, Kim S, Liu Y, Robeson S, Rosario G, McWilliams Wilson K, Reimschuessel R. 2014. Investigation of Listeria, Salmonella, and toxigenic Escherichia coli in various pet foods. Foodborne Pathog Dis 11:706–709. https://doi.org/10.1089/fpd.2014.1748 12. Davies RH, Lawes JR, Wales AD. 2019. Raw diets for dogs and cats: a review, with particular reference to microbiological hazards. J of Small Animal Practice 60:329–339. https://doi. org/10.1111/jsap.13000 13. Bottari B, Bancalari E, Barera A, Ghidini S, Gatti M. 2020. Evaluating the presence of human pathogens in commercially frozen, biologically appropriate raw pet food sold in Italy. Vet Rec 187:e50. https://doi.org/1 0.1136/vr.105893 14. Bernaquez I, Dumaresq J, Picard I, Gaulin C, Dion R, Weaver K, Walker M, Kearney A, Bharat A, Fafard J, Bekal S. 2025. Dogs fed raw meat-based diets are vectors of drug-resistant Salmonella infection in humans. Commun Med (Lond) 5:214. https://doi. org/10.1038/s43856-025-00919-2 15. Viegas FM, Ramos CP, Xavier RGC, Lopes EO, Júnior CAO, Bagno RM, Diniz AN, Lobato FCF, Silva ROS. 2020. Fecal shedding of Salmonella spp., Clostridium perfringens, and Clostridioides difficile in dogs fed raw meatbased diets in Brazil and their owners’ motivation. PLoS One 15:e0231275. https://doi. org/10.1371/journal.pone.0231275 16. Finley R, Ribble C, Aramini J, Vandermeer M, Popa M, Litman M, ReidSmith R. 2007. The risk of salmonellae shedding by dogs fed Salmonellacontaminated commercial raw food diets. Can Vet J 48:69–75. 17. Stull JW, Weese JS. 2015. Hospital-associated infections in small animal practice. Vet Clin North Am Small Anim Pract 45:217–233, https://doi.org/10.1016/j.cvsm.2014.11.009 18. Ward MP, Brady TH, Couëtil LL, Liljebjelke K, Maurer JJ, Wu CC. 2005. Investigation and control of an outbreak of salmonellosis caused by multidrug-resistant Salmonella typhimurium in a population of hospitalized horses. Vet Microbiol 107:233–240. https://doi.org/10.1016/ j.vetmic.2005.01.019 19. Dallap Schaer BL, Aceto H, Rankin SC. 2010. Outbreak of salmonellosis caused by Salmonella enterica serovar Newport MDR-AmpC in a large animal veterinary teaching hospital. J Vet Intern Med 24:1138–1146. http s://doi.org/10.1111/j.19391676.2010.0546.x 20. DeStefano IM, Fellman CL, Vagnone PMS, Cumming MA, Dale JL, Ruhland A, Dietrich J, Brown CM, Fortes E, Epie NN, Beaudoin A, Janiszewski K, Leaf J, Doron S, Doucette M, Cole SD. 2025. Human cases of carbapenemase-producing Escherichia coli linked to spread between animals and the environment in a veterinary facility—Massachusetts, USA, 2023. Clin Infect Dis. https://doi.org/10.1093/cid/ciaf541 21. DeStefano I, Fellman CL, Bergeron AC, Golato LM, Doron S, Cumming M, Brown CM, Leaf J, Dietrich J, Wagner R, Cole SD. 2025. Effective mitigation of an outbreak of New Delhi metallo-β-lactamase-producing Escherichia coli infections in a small animal veterinary teaching hospital. J Am Vet Med Assoc 263:1–10. https://doi.org/10.2460/javma.24.09.0572 22. Price ER, McDermott D, Sherman A, Kelley L, Mehr J, Greeley R, Cole SD. 2024. Canine multidrug-resistant Pseudomonas aeruginosa cases linked to human artificial tears-related outbreak. Emerg Infect Dis 30:2689–2691. https://doi.org/10.3201/ eid3012.240085 22. Cole SD, Peak L, Tyson GH, Reimschuessel R, Ceric O, Rankin SC. 2020. New Delhi metallo-β-lactamase-5-producing Escherichia coli in companion animals, United States. Emerg Infect Dis 26:381–383. https:// doi.org/10.3201/eid2602.191221 23. Waltenburg MA, Shugart A, Loy JD, Tewari D, Zhang S, Cole SD, Walters MS, Nichols M. 2022. A survey of current activities and technologies used to detect carbapenem resistance in bacteria isolated from companion animals at veterinary diagnostic laboratories-United States, 2020. J Clin Microbiol 60:e0215421. https://doi.org/10.1128/JCM.02154-21 24. Velayudhan BT, Naikare HK. 2022. Point-of-care testing in companion and food animal disease diagnostics. Front Vet Sci 9:1056440. https://doi .org/10.3389/fvets.2022.1056440 25. Ipsos. 2025. Trust in public health agencies declines. Available from: http s://www.ipsos.com/en-us/axios-ipsos-americanhealth-index v Leading Article A raw deal ..... <<< 7 Email: assistant@sava.co.za ADVERTISE IN VETNEWS MAGAZINE
Vetnuus | January 2026 9 Unprecedented high level of highly pathogenic avian influenza in wild birds in Europe during the 2025 autumn migration European Food Safety Authority, European Union Reference Laboratory for Avian Influenza, Mariette Ducatez, Alice Fusaro, Jose L Gonzales, Thijs Kuiken, Karl Ståhl, Christoph Staubach, Calogero Terregino and Lisa Kohnle 1 World Organisation for Animal Health (WOAH) (2025) – WAHIS periodical extraction of early warning outbreak data. Retrieved on 14 November 2025. Data extracted by EFSA. WOAH bears no responsibility for the integrity or accuracy of the data contained herein, not limited to: any deletion, manipulation, or reformatting of data that may have occurred beyond its control. Abstract Between 6 September and 14 November 2025, 1,443 highly pathogenic avian influenza (HPAI) A(H5) virus detections were reported in wild birds across 26 countries in Europe. This number was four times higher than in the same period in 2024 and the highest overall for those weeks since at least 2016. Almost all the detections (99%) were due to HPAI A(H5N1) viruses, and most of them belonged to EA-2024-DI.2.1, a new sub-lineage of the EA2024-DI.2 genotype. These HPAI virus detections in wild birds involved increasing numbers of waterfowl species (ducks, geese and swans) that were found positive in large parts of Europe. In addition, high numbers of common cranes were affected across a wide band stretching from northeast to southwest Europe. Given the unprecedentedly high circulation of HPAI virus in the wild bird population compared to previous years, and the associated high environmental contamination, strict biosecurity measures and early detection of infected poultry establishments are urgently needed to prevent introductions from wild to domestic birds and further spread among poultry establishments. Prompt removal of wild bird carcasses is indicated to reduce the risk of infection for other wild and domestic birds and mammals. Map disclaimer: The designations employed and the presentation of material on any maps included in this scientific output do not imply the expression of any opinion whatsoever on the part of the European Food Safety Authority concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Introduction This EFSA statement was requested by the European Commission (EC) under the mandate M-2024-00009 due to the quickly evolving situation with a very high level of highly pathogenic avian influenza (HPAI) virus circulation in wild birds during the current autumn migration. It provides an overview of all HPAI virus detections reported in wild birds in Europe between 6 September and 14 November 2025. Specific recommendations for the current period are provided at the end of this document. Data This EFSA statement includes data from European Union (EU) Member States and other third countries reporting via the Animal Disease Information System (ADIS), and data from the United Kingdom collected via the World Animal Health Information System (WOAHWAHIS) of the World Organisation for Animal Health (WOAH)1. Data extraction for the period from 6 September to 14 November 2025 was carried out on 14 November 2025. Results During the current reporting period from 6 September to 14 November 2025, a total of 1,443 HPAI virus detections in wild birds (with an HPAI virus detection potentially including more than one wild bird species) were reported in Europe. Compared to the same dates in previous years, this number was four times higher than in 2024, ten times higher than in 2023, twice as high as in 2022, and four times higher than in 2021 (Figure 1). Such a sharp increase and high number of HPAI virus detections in wild birds is unprecedented at this time of the year and has not been observed since at least 2016. The number of HPAI infections in wild birds likely found dead during the current reporting period is much higher than reported here, because not all recent HPAI virus detections have been reported yet, and because the number of reported HPAI virus detections in wild birds is an underrepresentation of the actual HPAI-associated mortality of wild birds. At the same time, these HPAI virus detections in wild birds were widespread geographically, with reports from 26 countries in Europe: Germany (909), France (165), Netherlands (78), United Kingdom (excluding Northern Ireland) (60), Spain (48), Denmark (28), Austria (24), Belgium (22), Luxembourg (17), Italy (16), Norway (14), Latvia (9), Sweden (9), Iceland (7), Lithuania (6), Poland (6), Portugal (5), Finland (4), Hungary (3), Slovenia (3), Czechia (2), Ireland (2), Romania (2), Switzerland (2), Slovakia (1) and Ukraine (1) (Figure 2). >>>10 Figure 1: Distribution of the number of HPAI virus detections in wild birds (cumulative number n = 14,227) (pink) and establishments keeping domestic birds (cumulative n = 7,268) (blue) reported in Europe during seven epidemiological years by month of suspicion, from 1 October 2019 to 14 November 2025 (total n = 21,495)
Vetnews | Januarie 2026 10 « BACK TO CONTENTS In parallel, an increase in HPAI outbreaks in domestic birds (Figure 1) was observed in many countries, likely as a consequence of high levels of virus circulation in wild birds and high contamination of the environment. Observations from previous epidemiological years indicate a correlation of HPAI presence in waterfowl and incursions into domestic birds. Overall, 1,424 HPAI virus detections in wild birds (99%) were reported as A(H5N1), nine as A(H5N5) and ten as A(H5Nx) (Figure 2). Based on genetic data available so far, most of the HPAI A(H5N1) viruses identified were a variant of the previously circulating EA2024-DI.2 genotype, which has mutated sufficiently to form a new sub-lineage, namely EA-2024.DI.2.1. Phylogenetic analysis indicates that this sub-lineage was probably newly introduced into Europe during autumn migration from the east and rapidly spread westward. The majority of HPAI A(H5) virus detections in wild birds were in waterfowl and common cranes. In particular, there were 426/1,443 (29.5%) detections in waterfowl (ducks, geese and swans) (Figure 3; Figure 4, upper panel), with mortality in mute swans reported in various parts of Europe, e.g. in the United Kingdom, France and Italy. In addition to the detections in dead birds, HPAI virus was identified in apparently healthy wild ducks through active surveillance activities (e.g. prevalence in apparently healthy mallards in the Netherlands was higher than ever before), indicating an even higher circulation of HPAI viruses in the wild bird population than the number of HPAI virus detections in wild birds found dead suggests. Moreover, the contemporaneous high prevalence of low pathogenic avian influenza (LPAI) and HPAI A(H5) viruses in wild waterfowl, as demonstrated by the SENTINEL Wild Birds project in recent weeks (https://zenodo.org/records/17696338), increases the chance of mixed infections potentially resulting in new reassortant viruses that play an important role in the rapid evolution of HPAI A(H5) viruses. In addition, there were 877/1,443 (61%) HPAI virus detections in which common cranes were involved: 115/128 (90%) among the ‘Mixed’ category (Figure 3; Figure 4, upper panel) and 762/801 (95%) among the ‘Others’ category (Figure 3; Figure 4, lower panel). Mass mortality of common cranes was first reported in Germany, where the first spillover to this species likely occurred. Subsequently, HPAI virus detections in common cranes were reported in France and Spain, following a southwest direction along their migratory route (Figure 4, lower panel). There were fewer HPAI virus detections in the other wild bird categories: colony-breeding seabirds and raptors. There were 44/1,443 (30.5%) detections in colony-breeding seabirds, mainly gull species, and the same number (44/1,443; 30.5%) in raptors, mainly Eurasian buzzards (Figure 3; Figure 4, upper panel). Based on the sharp increase, high level and wide geographical distribution of HPAI virus detections reported in wild birds during the current reporting period, it is expected that high levels of HPAI virus circulation in wild birds in Europe are likely to continue and to expand to other geographical areas in coming weeks as wild birds continue to migrate to their wintering areas in Europe and Africa. Unless additional measures are taken, this will likely lead to increased virus incursion into poultry and other captive bird Article Notes: The unit reported is the number of HPAI virus detections at outbreak level and not the total number of HPAI virus detections in wild birds (as more than one species can be involved in one single HPAI virus detection reported). *This designation is without prejudice to positions on status and is in line with United Nations Security Council Resolution 1244 and the International Court of Justice Opinion on the Kosovo Declaration of Independence. Source: ADIS, EFSA and WOAH (data extraction carried out on 14 November 2025). Figure 2: Geographic distribution, based on available geocoordinates, of HPAI virus detections in wild birds (1,443), reported by virus subtype, in Europe from 6 September to 14 November 2025 Notes: The unit reported is the number of HPAI virus detections in different wild bird categories at outbreak level and not the total number of HPAI virus detections in wild birds (as more than one species can be involved in one single HPAI virus detection reported). *This designation is without prejudice to positions on status and is in line with United Nations Security Council Resolution 1244 and the International Court of Justice Opinion on the Kosovo Declaration of Independence. *‘Mixed’ refers to outbreaks in which multiple categories were involved. **‘Others’ groups all other affected categories that are not indicated in the legend. Source: ADIS, EFSA and WOAH (data extraction carried out on 14 November 2025). Figure 3: Geographic distribution, based on available geocoordinates, of HPAI virus detections in different categories of wild birds in Europe, by species category, from 6 September to 14 November 2025 (total n = 1,443) Unprecedented high level of highly pathogenic avian influenza in wild birds in Europe....... <<< 9
Vetnuus | January 2026 11 establishments, as well as higher mortality of wild birds and mammals. Therefore, people and organisations involved with domestic or wild birds, or mammals, at risk for HPAI need to account for this unprecedented high level of HPAI virus circulation to prevent or reduce further virus spread. However, on no account should the concern about HPAI result in killing or disturbing wild birds or damaging their habitat. Not only would such measures be ineffective, but they also contravene national and international agreements to protect wild birds and their habitats. Recommendations • Biosecurity measures in domestic bird establishments and compliance thereof should be optimised and maintained at a high level both during the production cycle and culling operations. • Housing orders for domestic birds are highly recommended in areas where HPAI is circulating in wild birds or mass mortality events in wild birds are reported. • Surveillance in domestic birds should be enhanced to ensure early detection of infected poultry establishments. • Surveillance activities in wild birds should be enhanced, particularly in wetland areas and migratory stopover sites in and outside Europe. • EFSA’s Bird Flu Radar may be consulted to monitor the probability of HPAI virus introduction in wild bird populations over space and time: https://app.bto.org/hpai • Wildlife rescue/rehabilitation centres should be part of surveillance activities and implement adequate biosecurity to protect both animal and public health. • Artificial feeding of wild birds, particularly of cranes and swans, should be avoided during high-risk periods to reduce the level of crowding of these species. • Prompt removal of wild bird carcasses is indicated to reduce the level of virus contamination in the environment and subsequent possible infection of other wild and domestic birds and mammals. • Unnecessary disturbance of wild bird populations (e.g. hunting activities, tourism, leisure activities, use of drones) should be avoided to limit further dispersal of the virus. doi: 10.2903/j.efsa.2025.9811 This is an open-access article under the terms of the Creative Commons Attribution-NoDerivs Licence, which permits use and distribution in any medium, provided the original work is properly cited, and no modifications or adaptations are made. v Notes: The unit reported is the number of HPAI virus detections in different wild bird categories at outbreak level and not the total number of HPAI virus detections in wild birds (as more than one species can be involved in one single HPAI virus detection reported). *This designation is without prejudice to positions on status and is in line with United Nations Security Council Resolution 1244 and the International Court of Justice Opinion on the Kosovo Declaration of Independence. *‘Mixed’ refers to outbreaks in which multiple categories were involved. Source: ADIS, EFSA and WOAH (data extraction carried out on 14 November 2025) Figure 4: Geographic distribution, based on available geocoordinates, of HPAI virus detections in all wild bird categories apart from ‘Others’ (upper panel, total n = 642), and in the ‘Others’ wild bird category only (lower panel, total n = 801), in Europe, from 6 September to 14 November 2025 Article
Vetnews | Januarie 2026 12 « BACK TO CONTENTS Avian Polyomavirus (Papovavirus, Budgerigar Fledgling Disease, Psittacine Polyomavirus) Avian polyomavirus (APV) causes disease in young parrots. There are two forms of the disease based on affected species: budgerigar fledgling disease and non-budgerigar polyoma infection. Both are characterized by peracute to acute death of preweaned neonates. Clinical signs occur 7–10 days after exposure and include lethargy, crop stasis, and death within 24–48 hours. Surviving budgerigars >3 weeks old often exhibit feather dystrophy (French molt or feather dusters). Older nonbudgerigar psittacines may have subclinical disease or hemorrhages and coagulopathies. Adult birds typically are resistant to infection; they will seroconvert and shed the virus for up to 90 days, then clear the infection. Antemortem diagnosis is accomplished with DNA probes of cloacal swab and blood samples. Aviary control methods include not housing budgerigars or lovebirds with other species, strict hygiene, limiting traffic in the nursery, and strict quarantine and testing of new birds. A vaccination is available. The typical presentation of budgerigar fledging disease is a wellfleshed juvenile, just before fledgling age, with acute onset of lethargy, crop stasis, and death within 24–48 hours. Other clinical signs are cutaneous hemorrhage, abdominal distention, and feather abnormalities. Surviving budgerigars >3 weeks old often exhibit feather dystrophy (French molt or feather dusters). In other species of psittacines < 4 months old, the infection is often fatal. Older nonbudgerigar psittacines may have subclinical disease or hemorrhages and coagulopathies. Antemortem diagnosis is accomplished with DNA probes of cloacal swab and blood samples and virus-neutralizing antibody tests of blood samples to identify birds with previous viral exposure. Diagnosis in a flock setting is typically based on clinical signs, signalment, and necropsy findings.Gross necropsy findings in deceased chicks often include pale skeletal musculature and subcutaneous ecchymotic hemorrhages. The kidneys and liver are enlarged and may be pale, congested, and mottled, or have pinpoint, white foci. Petechial or ecchymotic hemorrhages may also be present on viscera, particularly the heart. The heart is sometimes enlarged and may show hydropericardium. Intranuclear inclusion bodies are often seen in the liver, kidneys, heart, spleen, bone marrow, uropygial gland, skin, feather follicles, etc. Aviary control methods include avoiding the housing of budgerigars or lovebirds on premises where other species are bred, adhering to standard hygiene procedures, preventing access to the nursery by visitors, and not introducing birds into the aviary without 90 days quarantine and testing. Eliminating APV infection from an infected budgerigar aviary is challenging. First, all breeding must be stopped for 6 months. The presence of infected neonates, fledglings, and adults propagates the disease. During this time, adult birds are moved to a noninfected area while the entire aviary is disinfected. Nest boxes should be disinfected or discarded and replaced. After 6 months, adult breeding birds can be returned to a clean aviary and breeding resumed. Pet store prevention should include separating neonates from different sources, purchasing birds from sources where polyomavirus testing and vaccination are performed, and ideally, not purchasing or selling unweaned birds. Treatment is supportive care. A vaccine is available. For breeding birds, two doses of the vaccine are administered at a 2-week interval; this should be done off-season. The manufacturer recommends administration of the first dose when the chick is >35 days old, with a booster vaccination in 2–3 weeks. Psittacine Beak and Feather Disease Psittacine beak and feather disease (PBFD) is caused by a psittacine circovirus. The virus was first recognized in the 1970s in cockatoos with beak and feather lesions. Since then, it has been recognized in most species of parrots and also in Passeriformes and Columbiformes. It primarily affects young parrots. Infected birds present with abnormal feathers, beak lesions, and immunosuppression. Infected birds shed virus in their feathers, feather dander, feces, and oral secretions. Transmission occurs by inhalation and/or ingestion of the virus and can occur vertically. The virus is very stable in the environment, so fomites are a notable source of infection. Diagnosis is based on clinical signs and results of PCR testing. Treatment is supportive care. Due to its contagious nature and terminal outcome, humane euthanasia may be warranted. Control involves strict hygiene, testing, and quarantine of all new birds. Clinical Findings of Avian Polyomavirus Viral Diseases of Pet Birds By Sharman M. Hoppes, DVM, DABVP (Avian), Texas Avian & Exotic Hospital Diagnosis of Avian Polyomavirus Treatment and Control of Avian Polyomavirus
RkJQdWJsaXNoZXIy OTc5MDU=